Vitamin D modulates adipose tissue biology: Possible consequences for obesity?

Proceedings of the Nutrition Society

Volumn 75, Issue 1, 2016, Pages 38-46

  Landrier, Jean François ^a,b,c   Karkeni, Esma ^a,b,c   Marcotorchino, Julie ^a,b,c   Bonnet, Lauriane ^a,b,c   Tourniaire, Franck ^a,b,c  

^a INSERM   (France)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Adipocytes; Adipose tissue; Inflammation; Nutrients; Nutrition; Obesity; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; VITAMIN D; VITAMIN D RECEPTOR;

ADIPOCYTE; ADIPOSE TISSUE; ANTIINFLAMMATORY ACTIVITY; CONFERENCE PAPER; CROSS-SECTIONAL STUDY; CYTOLOGY; DISEASE ASSOCIATION; ENERGY METABOLISM; EXPERIMENTAL MODEL; HUMAN; HYDROXYLATION; IN VITRO STUDY; INSULIN RESISTANCE; MEDICAL RESEARCH; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY; TISSUE METABOLISM; VITAMIN D DEFICIENCY; VITAMIN METABOLISM;

EID: 84959540018     PISSN: 00296651     EISSN: 14752719     Source Type: Journal    
DOI: 10.1017/S0029665115004164     Document Type: Conference Paper

References (122)

1. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357, 266-281.
2. Holick MF, Binkley NC, Bischoff-Ferrari HA et al. (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96, 1911-1930.
3. Schmid A & Walther B (2013) Natural vitamin d content in animal products. Adv Nutr 4, 453-462.
4. Holick MF (2011) Vitamin D: a D-lightful solution for health. J Investig Med 59, 872-880.
5. Heaney RP, Armas LA & French C (2013) All-source basal vitamin d inputs are greater than previously thought and cutaneous inputs are smaller. J Nutr 143, 571-575.
6. Mawer EB, Backhouse J, Holman CA et al. (1972) The distribution and storage of vitamin D and its metabolites in human tissues. Clin Sci 43, 413-431.
7. Blum M, Dolnikowski G, Seyoum E et al. (2008) Vitamin D (3) in fat tissue. Endocrine 33, 90-94.
8. Pramyothin P, Biancuzzo RM, Lu Z et al. (2011) Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after roux-en-Y gastric bypass. Obesity (Silver Spring) 19, 2228-2234.
9. Landrier JF, Marcotorchino J & Tourniaire F (2012) Lipophilic micronutrients and adipose tissue biology. Nutrients 4, 1622-1649.
10. Marcotorchino J, Tourniaire F & Landrier JF (2013) Vitamin D, adipose tissue, and obesity. Horm Mol Biol Clin Investig 15, 123-128.
11. Beckman LM, Earthman CP, Thomas W et al. (2013) Serum 25 (OH) vitamin D concentration changes after Roux-en-Y gastric bypass surgery. Obesity (Silver Spring) 21, E599-606.
12. Heaney RP, Horst RL, Cullen DM et al. (2009) Vitamin D3 distribution and status in the body. J Am Coll Nutr 28, 252-256.
13. Piccolo BD, Dolnikowski G, Seyoum E et al. (2013) Association between subcutaneous white adipose tissue and serum 25-hydroxyvitamin D in overweight and obese adults. Nutrients 5, 3352-3366.
14. Heaney RP, Armas LA, Shary JR et al. (2008) 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 87, 1738-1742.
15. Malmberg P, Karlsson T, Svensson H et al. (2014) A new approach to measuring vitamin D in human adipose tissue using time-of-flight secondary ion mass spectrometry: a pilot study. J Photochem Photobiol B 138, 295-301.
16. Borel P, CaillaudD & CanoNJ (2015) Vitamin d bioavailability: state of the art. Crit Rev Food Sci Nutr 55, 1193-1205.
17. Reboul E, Goncalves A, Comera C et al. (2011) Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol Nutr Food Res 55, 691-702.
18. Reboul E (2015) Intestinal absorption of vitamin D: from the meal to the enterocyte. Food Funct 6, 356-362.
19. Daiger SP, Schanfield MS & Cavalli-Sforza LL (1975) Group-specific component (Gc) proteins bind vitamin D and 25-hydroxyvitamin D. Proc Natl Acad Sci USA 72, 2076-2080.
20. Haddad JG, Jennings AS & Aw TC (1988) Vitamin D uptake and metabolism by perfused rat liver: influences of carrier proteins. Endocrinology 123, 498-504.
21. Speeckaert M, Huang G, Delanghe JR et al. (2006) Biological and clinical aspects of the vitamin D binDing protein (Gc-globulin) and its polymorphism. Clin Chim Acta 372, 33-42.
22. Mendel CM (1989) The free hormone hypothesis: a physiologically based mathematical model. Endocr Rev 10, 232-274.
23. SafaDi FF, Thornton P, Magiera H et al. (1999) Osteopathy and resistance to vitamin D toxicity in mice null for vitamin D binDing protein. J Clin Invest 103, 239-251.
24. Zella LA, Shevde NK, Hollis BW et al. (2008) Vitamin D-binDing protein influences total circulating levels of 1, 25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo. Endocrinology 149, 3656-3667.
25. Abboud M, Gordon-Thomson C, Hoy AJ et al. (2013) Uptake of 25-hydroxyvitamin D by muscle and fat cells. J Steroid Biochem Mol Biol 144, 232-236.
26. Moussa M, Gouranton E, Gleize B et al. (2011) CD36 is involved in lycopene and lutein uptake by adipocytes and adipose tissue cultures. Mol Nutr Food Res 55, 578-584.
27. Jones KS, Schoenmakers I, Bluck LJ et al. (2012) Plasma appearance and disappearance of an oral dose of 25-hydroxyvitamin D2 in healthy adults. Br J Nutr 107, 1128-1137.
28. Cheng JB, Motola DL, Mangelsdorf DJ et al. (2003) De-orphanization of cytochrome P450 2R1: a microsomal vitamin D 25-hydroxilase. J Biol Chem 278, 38084-38093.
29. Schuster I (2011) Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta 1814, 186-199.
30. Zhu J & DeLuca HF (2012) Vitamin D 25-hydroxylase-four decades of searching, are we there yet? Arch Biochem Biophys 523, 30-36.
31. Gupta RP, Hollis BW, Patel SB et al. (2004) CYP3A4 is a human microsomal vitamin D 25-hydroxylase. J Bone Miner Res 19, 680-688.
32. Aiba I, Yamasaki T, Shinki T et al. (2006) Characterization of rat and human CYP2J enzymes as vitamin D 25-hydroxylases. Steroids 71, 849-856.
33. Guo YD, Strugnell S, Back DW et al. (1993) Transfected human liver cytochrome P-450 hydroxylates vitamin D analogs at different side-chain positions. Proc Natl Acad Sci U S A 90, 8668-8672.
34. Yamasaki T, Izumi S, Ide H et al. (2004) Identification of a novel rat microsomal vitamin D3 25-hydroxylase. J Biol Chem 279, 22848-22856.
35. Postlind H, Axen E, Bergman T et al. (1997) Cloning, structure, and expression of a cDNA encoDing vitamin D3 25-hydroxylase. Biochem Biophys Res Commun 241, 491-497.
36. Rahmaniyan M, Patrick K & Bell NH (2005) Characterization of recombinant CYP2C11: a vitamin D 25-hydroxylase and 24-hydroxylase. Am J Physiol Endocrinol Metab 288, E753-E760.
37. Zoico E, Franceschetti G, Chirumbolo S et al. (2014) Phenotypic shift of adipocytes by cholecalciferol and 1alpha, 25 dihydroxycholecalciferol in relation to inflammatory status and calcium content. Endocrinology 155, 4178-4188.
38. Wamberg L, Christiansen T, Paulsen SK et al. (2012) Expression of vitamin D-metabolizing enzymes in human adipose tissue-the effect of obesity and diet-induced weight loss. Int J Obes (Lond) 37, 651-657.
39. Nykjaer A, Dragun D, Walther D et al. (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell 96, 507-515.
40. Dusso AS, Brown AJ, Slatopolsky E (2005) Vitamin D. Am J Physiol Renal Physiol 289, F8-F28.
41. Gacad MA, Chen H, Arbelle JE et al. (1997) Functional characterization and purification of an intracellular vitamin D-binDing protein in vitamin D-resistant new world primate cells. Amino acid sequence homology with proteins in the hsp-70 family. J Biol Chem 272, 8433-8440.
42. Teegarden D, Nickel KP & Shi L (2000) Characterization of 25-hydroxyvitamin D binDing protein from intestinal cells. Biochem Biophys Res Commun 275, 845-849.
43. Li J, Byrne ME, Chang E et al. (2008) 1alpha, 25-Dihydroxyvitamin D hydroxylase in adipocytes. J Biochem Mol Biol 112, 122-126.
44. Ching S, Kashinkunti S, Niehaus MD et al. (2011) Mammary adipocytes bioactivate 25-hydroxyvitamin D (3) and signal via vitamin D (3) receptor, modulating mammary epithelial cell growth. J Cell Biochem 112, 3393-3405.
45. Nimitphong H, Holick MF, Fried SK et al. (2012) 25-hydroxyvitamin d (3) and 1, 25-dihydroxyvitamin d (3) promote the differentiation of human subcutaneous preadipocytes. PLoS ONE 7, e52171.
46. Lips P (2006) Vitamin D physiology. Prog Biophys Mol Biol 92, 4-8.
47. Carlberg C & Seuter S (2009) A genomic perspective on vitamin D signaling. Anticancer Res 29, 3485-3493.
48. Bikle DD, Gee E & Pillai S (1993) Regulation of keratinocyte growth, differentiation, and vitamin D metabolism by analogs of 1, 25-dihydroxyvitamin D. J Invest Dermatol 101, 713-718.
49. Bouillon R, Carmeliet G, Verlinden L et al. (2008) Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev 29, 726-776.
50. Issa LL, Leong GM & Eisman JA (1998) Molecular mechanism of vitamin D receptor action. Inflamm Res 47, 451-475.
51. Plum LA & DeLuca HF (2010) Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov 9, 941-955.
52. Kamei Y, Kawada T, Kazuki R et al. (1993) Vitamin D receptor gene expression is up-regulated by 1, 25-dihydroxyvitamin D3 in 3T3-L1 preadipocytes. Biochem Biophys Res Commun 193, 948-955.
53. Clemente-Postigo M, Munoz-Garach A, Serrano M et al. (2015) Serum 25-hydroxyvitamin d and adipose tissue vitamin d receptor gene expression: relationship with obesity and type 2 diabetes. J Clin Endocrinol Metab 100, E591-E595.
54. Turano C, Gaucci E, Grillo C et al. (2011) ERp57/GRP58: a protein with multiple functions. Cell Mol Biol Lett 16, 539-563.
55. Nemere I, Safford SE, Rohe B et al. (2004) Identification and characterization of 1, 25D3-membrane-associated rapid response, steroid (1, 25D3-MARRS) binDing protein. J Steroid Biochem Mol Biol 89-90, 281-285.
56. Nemere I & Hintze K (2008) Novel hormone 'receptors'. J Cell Biochem 103, 401-407.
57. Lisse TS, Adams JS & Hewison M (2013) Vitamin D and microRNAs in bone. Crit Rev Eukaryot Gene Expr 23, 195-214.
58. Ishida Y, Taniguchi H & Baba S (1988) Possible involvement of 1 alpha, 25-dihydroxyvitamin D3 in proliferation and differentiation of 3T3-L1 cells. Biochem Biophys Res Commun 151, 1122-1127.
59. Kong J & Li YC (2006) Molecular mechanism of 1, 25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells. Am J Physiol Endocrinol Metab 290, E916-E924.
60. Blumberg JM, Tzameli I, Astapova I et al. (2006) Complex role of the vitamin D receptor and its ligand in adipogenesis in 3T3-L1 cells. J Biol Chem 281, 11205-11213.
61. Mutt SJ, Hypponen E, Saarnio J et al. (2014) Vitamin D and adipose tissue-more than storage. Front Physiol 5, 228.
62. Vu D, Ong JM, Clemens TL et al. (1996) 1, 25-Dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation. Endocrinology 137, 1540-1544.
63. Farmer SR (2006) Transcriptional control of adipocyte formation. Cell Metab 4, 263-273.
64. RicciarDi CJ, Bae J, Esposito D et al. (2014) 1, 25-Dihydroxyvitamin D/vitamin D receptor suppresses brown adipocyte differentiation and mitochondrial respiration. Eur J Nutr 54, 1001-1012.
65. Narvaez CJ, SimmonsKM, Brunton J et al. (2013) Induction of STEAP4 correlates with 1, 25-dihydroxyvitamin D3 stimulation of adipogenesis in mesenchymal progenitor cells derived from human adipose tissue. J Cell Physiol 228, 2024-2036.
66. Kong J, ChenY, ZhuGet al. (2013) 1, 25-Dihydroxyvitamin D3 upregulates leptin expression in mouse adipose tissue. J Endocrinol 216, 265-271.
67. Marcotorchino J, Gouranton E, Romier B et al. (2012) Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol Nutr Food Res 56, 1771-1782.
68. Manna P & Jain SK (2012) Vitamin D upregulates glucose transporter 4 (GLUT4) translocation and glucose utilization mediated by cystathionine-gamma-lyase (CSE) activation and H2S formation in 3T3L1 adipocytes. J Biol Chem 287, 42324-42332.
69. Marcotorchino J, Tourniaire F, Astier J et al. (2014) Vitamin D protects against diet-induced obesity by enhancing fatty acid oxidation. J Nutr Biochem 25, 1077-1083.
70. Sergeev IN & Song Q (2014) High vitamin D and calcium intakes reduce diet-induced obesity in mice by increasing adipose tissue apoptosis. Mol Nutr Food Res 58, 1342-1348.
71. Domingues-Faria C, Chanet A, Salles J et al. (2014) Vitamin D deficiency down-regulates Notch pathway contributing to skeletal muscle atrophy in old Wistar rats. Nutr Metab (Lond) 11, 47.
72. Amara NB, Marcotorchino J, Tourniaire F et al. (2014) Multivitamin restriction increases adiposity and disrupts glucose homeostasis in mice. Genes Nutr 9, 410.
73. Sun X & Zemel MB (2007) Calcium and 1, 25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity (Silver Spring) 15, 340-348.
74. Sun X & Zemel MB (2008) Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J Nutr Biochem 19, 392-399.
75. Lorente-Cebrian S, Eriksson A, Dunlop T et al. (2012) Differential effects of 1alpha, 25-dihydroxycholecalciferol on MCP-1 and adiponectin production in human white adipocytes. Eur J Nutr 51, 335-342.
76. Gao D, Trayhurn P & BingC (2012) 1, 25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes. Int J Obes (Lond) 37, 357-365.
77. Mutt SJ, Karhu T, Lehtonen S et al. (2012) Inhibition of cytokine secretion from adipocytes by 1, 25-dihydroxyvitamin D (3) via the NF-kappaB pathway. FASEB J 26, 4400-4407.
78. Guillot X, Semerano L, Saidenberg-Kermanac'h N et al. (2010) Vitamin D and inflammation. Joint Bone Spine 77, 552-557.
79. Wamberg L, Cullberg KB, Rejnmark L et al. (2013) Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: results from an in vitro study and a randomized controlled trial. Horm Metab Res 45, 456-462.
80. Karkeni E, Marcotorchino J, Tourniaire F et al. (2015) Vitamin D limits chemokine expression in adipocytes and macrophage migration in vitro and in male mice. Endocrinology 156, 1782-1793.
81. Tourniaire F, Romier-Crouzet B, Lee JH et al. (2013) Chemokine expression in inflamed adipose tissue is mainly mediated by NF-kappaB. PLoS ONE 8, e66515.
82. Ding C, WilDing JP & Bing C (2013) 1, 25-dihydroxyvitamin D3 protects against macrophage-induced activation of NFkappaB and MAPK signalling and chemokine release in human adipocytes. PLoS ONE 8, e61707.
83. Suganami T, Nishida J & Ogawa Y (2005) A paracrine loop between adipocytes and macrophages aggravates inflammatory changes: role of free fatty acids and tumor necrosis factor alpha. Arterioscler Thromb Vasc Biol 25, 2062-2068.
84. Lira FS, Rosa JC, Cunha CA et al. (2011) Supplementing alpha-tocopherol (vitamin E) and vitamin D3 in high fat diet decrease IL-6 production in murine epididymal adipose tissue and 3T3-L1 adipocytes following LPS stimulation. Lipids Health Dis 10, 37.
85. Roth CL, Elfers CT, Figlewicz DP et al. (2012) Vitamin D deficiency in obese rats exacerbates nonalcoholic fatty liver disease and increases hepatic resistin and Toll-like receptor activation. Hepatology 55, 1103-1111.
86. Narvaez CJ, Matthews D, Broun E et al. (2009) Lean phenotype and resistance to diet-induced obesity in vitamin D receptor knockout mice correlates with induction of uncoupling protein-1 in white adipose tissue. Endocrinology 150, 651-661.
87. Wong KE, Szeto FL, ZhangWet al. (2009) Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am J Physiol Endocrinol Metab 296, E820-E828.
88. Wong KE, Kong J, Zhang Wet al. (2011) Targeted expression of human vitamin D receptor in adipocytes decreases energy expenditure and induces obesity in mice. J Biol Chem 286, 33804-33810.
89. Soares MJ, MurhaDi LL, Kurpad AV et al. (2012) Mechanistic roles for calcium and vitamin D in the regulation of body weight. Obes Rev 13, 592-605.
90. Rowling MJ, Gliniak C, Welsh J et al. (2007) High dietary vitamin D prevents hypocalcemia and osteomalacia in CYP27B1 knockout mice. J Nutr 137, 2608-2615.
91. Malloy PJ & Feldman BJ (2013) Cell-autonomous regulation of brown fat identity gene UCP1 by unliganded vitamin D receptor. Mol Endocrinol 27, 1632-1642.
92. Sun X & Zemel MB (2008) 1Alpha, 25-dihydroxyvitamin D and corticosteroid regulate adipocyte nuclear vitamin D receptor. Int J Obes (Lond) 32, 1305-1311.
93. Bouillon R, Carmeliet G, Lieben L et al. (2014) Vitamin D and energy homeostasis-of mice and men. Nat Rev Endocrinol 10, 79-87.
94. Gallagher JC, Yalamanchili V & Smith LM (2013) The effect of vitamin D supplementation on serum 25OHD in thin and obese women. J Steroid BiochemMol Biol 136, 195-200.
95. Pereira-Santos M, Costa PR, Assis AM et al. (2015) Obesity and vitamin D deficiency: a systematic review and meta-analysis. Obes Rev 16, 341-349.
96. Garcia OP, Long KZ & Rosado JL (2009) Impact of micronutrient deficiencies on obesity. Nutr Rev 67, 559-572.
97. Cheng S, Massaro JM, Fox CS et al. (2010) Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes 59, 242-248.
98. Caron-Jobin M, Morisset AS, Tremblay A et al. (2011) Elevated serum 25 (OH) D concentrations, vitamin D, and calcium intakes are associated with reduced adipocyte size in women. Obesity (Silver Spring) 19, 1335-1341.
99. Wortsman J, Matsuoka LY, Chen TC et al. (2000) Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 72, 690-693.
100. Drincic AT, Armas LA, Van Diest EE et al. (2012) Volumetric dilution, rather than sequestration best explains the low vitamin d status of obesity. Obesity (Silver Spring) 20, 1444-1448.
101. Parikh SJ, Edelman M, Uwaifo GI et al. (2004) The relationship between obesity and serum 1, 25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab 89, 1196-1199.
102. Konradsen S, Ag H, Lindberg F et al. (2008) Serum 1, 25-dihydroxy vitamin D is inversely associated with body mass index. Eur J Nutr 47, 87-91.
103. Bell NH (1985) Vitamin D-endocrine system. J Clin Invest 76, 1-6.
104. Mai XM, Chen Y, Camargo CA Jr. et al. (2012) Cross-sectional and prospective cohort study of serum 25-hydroxyvitamin D level and obesity in adults: the HUNT study. Am J Epidemiol 175, 1029-1036.
105. Gonzalez-Molero I, Rojo-Martinez G, Morcillo S et al. (2013) Hypovitaminosis D and incidence of obesity: a prospective study. Eur J Clin Nutr 67, 680-682.
106. Gilbert-Diamond D, Baylin A, Mora-Plazas M et al. (2010) Vitamin D deficiency and anthropometric indicators of adiposity in school-age children: a prospective study. Am J Clin Nutr 92, 1446-1451.
107. LeBlanc ES, Rizzo JH, Pedula KL et al. (2012) Associations between 25-hydroxyvitamin D and weight gain in elderly women. J Womens Health (Larchmt) 21, 1066-1073.
108. Gagnon C, Lu ZX, Magliano DJ et al. (2012) Low serum 25-hydroxyvitamin D is associated with increased risk of the development of the metabolic syndrome at five years: results from a national, population-based prospective study (The Australian Diabetes, Obesity and Lifestyle Study: AusDiab). J Clin Endocrinol Metab 97, 1953-1961.
109. Kamycheva E, Joakimsen RM & Jorde R (2003) Intakes of calcium and vitamin d predict body mass index in the population of Northern Norway. J Nutr 133, 102-106.
110. Teegarden D, White KM, Lyle RM et al. (2008) Calcium and dairy product modulation of lipid utilization and energy expenditure. Obesity (Silver Spring) 16, 1566-1572.
111. Boon N, Hul GB, Sicard A et al. (2006) The effects of increasing serum calcitriol on energy and fat metabolism and gene expression. Obesity (Silver Spring) 14, 1739-1746.
112. Salehpour A, Hosseinpanah F, Shidfar F et al. (2012) A 12-week double-blind randomized clinical trial of vitamin D (3) supplementation on body fat mass in healthy overweight and obese women. Nutr J 11, 78.
113. Zittermann A, Frisch S, Berthold HK et al. (2009) Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 89, 1321-1327.
114. Sneve M, FigenschauY & JordeR (2008) Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects. Eur J Endocrinol 159, 675-684.
115. Wamberg L, Kampmann U, Stodkilde-Jorgensen H et al. (2013) Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels-results from a randomized trial. Eur J Intern Med 24, 644-649.
116. Pathak K, Soares MJ, Calton EK et al. (2014) Vitamin D supplementation and body weight status: a systematic review and meta-analysis of randomized controlled trials. Obes Rev 15, 528-537.
117. Mason C, Xiao L, Imayama I et al. (2014) Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial. Am J Clin Nutr 99, 1015-1025.
118. Vimaleswaran KS, Berry DJ, Lu C et al. (2013) Causal relationship between obesity and vitamin D status: bidirectional Mendelian randomization analysis of multiple cohorts. PLoS Med 10, e1001383.
119. Wang TJ, Zhang F, Richards JB et al. (2010) Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 376, 180-188.
120. Dorjgochoo T, Shi J, Gao YT et al. (2012) Genetic variants in vitamin D metabolism-related genes and body mass index: analysis of genome-wide scan data of approximately 7000 Chinese women. Int J Obes (Lond) 36, 1252-1255.
121. Ochs-Balcom HM, Chennamaneni R, Millen AE et al. (2011) Vitamin D receptor gene polymorphisms are associated with adiposity phenotypes. Am J Clin Nutr 93, 5-10.
122. Sulistyoningrum DC, Green TJ, Lear SA et al. (2012) Ethnic-specific differences in vitamin D status is associated with adiposity. PLoS ONE 7, e43159.